Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYC |
| Upstream (Parents) |
|---|
| (<<) ATF5 → MYC |
| (<<) HHEX → MYC |
| (<<) AR → MYC |
| (<<) NR3C1 → MYC |
| (<<) PEG3 → MYC |
| (<<) KLF11 → MYC |
| Downstream (Children) |
|---|
| MYC → HOXA9 (>>) |
| MYC → HOXB13 (>>) |
| MYC → SATB2 (>>) |
| MYC → HMGA2 (>>) |
| MYC → DMRT1 (>>) |
| MYC → ESRRG (>>) |
| MYC → ZNF135 (>>) |
| MYC → PITX1 (>>) |
| MYC → ETV4 (>>) |
| MYC → KLF5 (>>) |
| MYC → PTH (>>) |
| MYC → GRHL2 (>>) |
| MYC → MAF (>>) |
| MYC → LEF1 (>>) |
| MYC → NFE2L3 (>>) |
| MYC → SOX9 (>>) |
| MYC → HMGA1 (>>) |
| MYC → FOXM1 (>>) |
| MYC → VDR (>>) |
| MYC → MLL (>>) |
| MYC → KLF12 (>>) |
| MYC → E2F8 (>>) |
| MYC → PTTG1 (>>) |
| MYC → BACH2 (>>) |
| MYC → RORA (>>) |
| MYC → E2F5 (>>) |
| MYC → ZNF165 (>>) |
| MYC → HOXD12 (>>) |
| MYC → PLAGL2 (>>) |
| MYC → GTF2IRD1 (>>) |
| MYC → HEY2 (>>) |
| MYC → POU5F1B (>>) |
| MYC → HMGB2 (>>) |
| MYC → TAF4B (>>) |
| MYC → RBCK1 (>>) |
| MYC → LASS6 (>>) |
